Born in July 1958, an independent non-executive director, the chairperson of the Audit Committee, and a member of the Nomination Committee and the Remuneration Committee of the Company. Mr. LAU Siu Ki became an independent non-executive director of the Company in November 2017. He graduated from The Hong Kong Polytechnic University in 1981. He is currently a financial advisory consultant of his management consultancy firm, Hin Yan Consultants Limited. Previously, Mr. LAU Siu Ki worked at Ernst & Young for over 15 years. He has over 35 years of experience in corporate governance, corporate financing, financial advisory and management, accounting and audit. Mr. LAU Siu Ki is currently a fellow member of both of ACCA and HKICPA. Mr. LAU Siu Ki was a member of the World Council of ACCA from 2002 to 2011 and was the chairperson of ACCA Hong Kong in 2000/2001. During these years, he has helped raising the profile of ACCA. Currently, Mr. LAU Siu Ki also serves as an independent non-executive director of Binhai Investment Company Limited (02886.HK), Comba Telecom Systems Holdings Limited (02342.HK), IVD Medical Holdings Limited (01931.HK), Embry Holdings Limited (01388.HK), Samson Holding Ltd. (00531.HK) and FIH Mobile Limited (02038.HK). He is also the company secretary of Hung Fook Tong Group Holdings Limited (01446.HK), Yeebo (International Holdings) Limited (00259.HK) and Expert Systems Holdings Limited (08319.HK). In 2021, the Market Misconduct Tribunal fined and made orders against China Medical & HealthCare Group Limited (a company whose shares are listed on the Hong Kong Stock Exchange with stock code: 00383.HK and which was formerly known as COL Capital Limited) and six then directors thereof including Mr. LAU Siu Ki (who served as an independent non-executive director between June 2004 to December 2018) for breach of the requirements of the corporate disclosure regime by the said company. For further details, please refer to the Company’s announcements dated 5 November 2019 and 13 May 2021.